Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study
Spriggs, D. R., Sherman, M. L., Michie, H., Arthur, K. A., Imamura, K., Wilmore, D., Frei, E., Kufe, D. W.Volume:
80
Language:
english
Journal:
JNCI Journal of the National Cancer Institute
DOI:
10.1093/jnci/80.13.1039
Date:
September, 1988
File:
PDF, 859 KB
english, 1988